ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000224460.1	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.022154373	Resistant
ENSG00000224460.1	ABT-263 (navitoclax)	Liver hepatocellular carcinoma	0.021099381	Sensitive